Acorda Therapeutics, Inc. Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31)
Acorda Therapeutics, Inc. reported Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) of $4.76 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FiniteLivedIntangibleAssetsFutureAmortizationExpense · last filed 2012-02-28
- Acorda Therapeutics, Inc. finite-lived intangible assets, future amortization expense (deprecated 2012-01-31) for fiscal 2011 was $4.76M.
| Period end | Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) 12 month | Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|
| 2011-12-31 | $4.76M 10-K · filed 2012-02-28 | |
| 2010-12-31 | $19.17M 10-Q · filed 2011-11-07 | $11.34M 10-Q · filed 2011-08-08 |